Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | K4JHJ | — |
pediatric dose of Engerix-B was administered to adult patient; Accidental underdose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult use of a child product in a 43-year-old female patient who received HBV (Engerix B pediatric) (batch number K4JHJ) for prophylaxis. On 06-FEB-2025, the patient received Engerix B pediatric. On 06-FEB-2025, an unknown time after receiving Engerix B pediatric, the patient experienced adult use of a child product (Verbatim: pediatric dose of Engerix-B was administered to adult patient) and accidental underdose (Verbatim: Accidental underdose). The outcome of the adult use of a child product and accidental underdose were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 06-FEB-2025 The reporter called to report that they accidentally administered a pediatric dose of Engerix-B to a female adult patient who is 43 years old which led to adult use of child product and underdose. The reporter enquired does the patient needs another dose for 20 years and older